These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 36795724)

  • 1. Construction and validation of a prognostic signature based on necroptosis-related genes in hepatocellular carcinoma.
    Peng YL; Wang LX; Li MY; Liu LP; Li RS
    PLoS One; 2023; 18(2):e0279744. PubMed ID: 36795724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration and validation of a novel signature of seven necroptosis-related genes to improve the clinical outcome of hepatocellular carcinoma.
    Tao Q; Lang Z; Li Y; Gao Y; Lin L; Yu Z; Zheng J; Yu S
    BMC Cancer; 2023 Oct; 23(1):1029. PubMed ID: 37875823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A necroptosis-related gene signature for predicting prognosis, immune landscape, and drug sensitivity in hepatocellular carcinoma.
    Chen J; Wang H; Zhou L; Liu Z; Chen H; Tan X
    Cancer Med; 2022 Dec; 11(24):5079-5096. PubMed ID: 35560794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma.
    Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ
    BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a Necroptosis-Related Prognostic Signature and Associated Regulatory Axis in Liver Hepatocellular Carcinoma.
    He A; Huang Z; Wang J; Lu H; Zhang R; Wu L; Feng Q
    Dis Markers; 2022; 2022():3968303. PubMed ID: 35855852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A necroptosis -related signature for predicting prognosis and immunotherapy in hepatocellular carcinoma.
    Fu X; Yang Y; Zhang X
    Front Genet; 2022; 13():919599. PubMed ID: 36134033
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
    Sun K; Huang C; Li JZ; Luo ZX
    World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a necroptosis-related gene signature as a novel prognostic biomarker of cholangiocarcinoma.
    Xu L; Gao X; Xing J; Guo Z
    Front Immunol; 2023; 14():1118816. PubMed ID: 36936916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Validation a Necroptosis-Related Prognostic Signature in Cervical Cancer.
    Yang Z; Li J; Tang Y; Zou L
    Reprod Sci; 2023 Jun; 30(6):2003-2015. PubMed ID: 36576713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a Necroptosis-Related Prognostic Signature to Reveal Immune Infiltration and Predict Drug Sensitivity in Hepatocellular Carcinoma.
    Ren H; Zheng J; Cheng Q; Yang X; Fu Q
    Front Genet; 2022; 13():900713. PubMed ID: 35957699
    [No Abstract]   [Full Text] [Related]  

  • 11. Development and validation of a robust immune-related risk signature for hepatocellular carcinoma.
    Liu Z; Jiao D; Liu L; Zhou X; Yao Y; Li Z; Li J; Chen J; Lei Q; Han X
    Medicine (Baltimore); 2021 Mar; 100(10):e24683. PubMed ID: 33725827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of molecular subtypes based on PANoptosis-related genes and construction of a signature for predicting the prognosis and response to immunotherapy response in hepatocellular carcinoma.
    Zhu J; Huang Q; Peng X; Luo C; Liu Z; Liu D; Yuan H; Yuan R; Cheng X
    Front Immunol; 2023; 14():1218661. PubMed ID: 37662906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and validation of the necroptosis-related gene signature related to prognosis and tumor immune in hepatocellular carcinoma.
    Xiang Z; Mranda GM; Zhou X; Xue Y; Wang Y; Wei T; Liu J; Ding Y
    Medicine (Baltimore); 2022 Sep; 101(36):e30219. PubMed ID: 36086716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five metastasis-related mRNAs signature predicting the survival of patients with liver hepatocellular carcinoma.
    Chen C; Liu YQ; Qiu SX; Li Y; Yu NJ; Liu K; Zhong LM
    BMC Cancer; 2021 Jun; 21(1):693. PubMed ID: 34116652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A signature based on neutrophil extracellular trap-related genes for the assessment of prognosis, immunoinfiltration, mutation and therapeutic response in hepatocellular carcinoma.
    Wang L; Wang Q; Li Y; Qi X; Fan X
    J Gene Med; 2024 Jan; 26(1):e3588. PubMed ID: 37715643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a necroptosis-related gene signature for making clinical predictions of the survival of patients with lung adenocarcinoma.
    Zhou X; Zhao M; Fan Y; Xu Y
    PeerJ; 2024; 12():e16616. PubMed ID: 38213773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and validation of a necroptosis-related lncRNAs prognosis signature of hepatocellular carcinoma.
    Peng Y; Wu G; Qiu X; Luo Y; Zou Y; Wei X; Li A
    Front Genet; 2022; 13():916024. PubMed ID: 36110223
    [No Abstract]   [Full Text] [Related]  

  • 18. Construction of a novel signature and prediction of the immune landscape in gastric cancer based on necroptosis-related genes.
    Li Z; Yang W; Liu D; Ye W; Du G; Li X
    Sci Rep; 2022 Aug; 12(1):13290. PubMed ID: 35918354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multi-omics-based investigation of the immunological and prognostic impact of necroptosis-related genes in patients with hepatocellular carcinoma.
    Yang H; Jiang Q
    J Clin Lab Anal; 2022 Apr; 36(4):e24346. PubMed ID: 35293027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
    BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.